Bulltick Wealth Management’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,887
Closed -$454K 117
2024
Q2
$454K Sell
4,887
-3,943
-45% -$360K 0.11% 71
2024
Q1
$823K Sell
8,830
-3,544
-29% -$321K 0.14% 70
2023
Q4
$1.07M Sell
12,374
-6,443
-34% -$534K 0.24% 68
2023
Q3
$1.55M Sell
18,817
-9,733
-34% -$826K 0.37% 55
2023
Q2
$2.43M Buy
28,550
+16,409
+135% +$1.4M 0.54% 48
2023
Q1
$1.01M Buy
12,141
+798
+7% +$66.1K 0.26% 57
2022
Q4
$963K Buy
11,343
+841
+8% +$69.4K 0.27% 54
2022
Q3
$791K Hold
10,502
0.24% 58
2022
Q2
$852K Buy
10,502
+454
+5% +$38K 0.23% 58
2022
Q1
$880K Buy
10,048
+324
+3% +$27.4K 0.2% 60
2021
Q4
$878K Buy
9,724
+675
+7% +$58.3K 0.17% 58
2021
Q3
$758K Buy
9,049
+1,950
+27% +$169K 0.17% 58
2021
Q2
$590K Hold
7,099
0.14% 60
2021
Q1
$547K Buy
7,099
+716
+11% +$55.1K 0.15% 51
2020
Q4
$488K Buy
+6,383
New +$470K 0.14% 53

Other funds holding IXJ

Bulltick Wealth Management's IXJ Position: Q3 2024 in Review

Bulltick Wealth Management sold out of iShares Global Healthcare ETF (IXJ) in Q3 2024, closing a stake of 4,887 shares — an estimated $454K sold.

Bulltick Wealth Management first reported a position in IXJ in Q4 2020 and held it in 15 quarters. The position peaked at $2.43M in Q2 2023. 273 funds tracked by Wall St. Rank hold IXJ as of Q3 2024.

  • Bulltick Wealth Management reported no remaining iShares Global Healthcare ETF position as of Q3 2024 after selling out during the quarter.
  • Bulltick Wealth Management sold 4,887 iShares Global Healthcare ETF shares in Q3 2024, an estimated $454K.
  • Bulltick Wealth Management first reported a position in iShares Global Healthcare ETF in Q4 2020 and held it in 15 quarters.
  • Bulltick Wealth Management's iShares Global Healthcare ETF position peaked at $2.43M in Q2 2023.
  • 273 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q3 2024.

Based on Bulltick Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.